Vanda Pharmaceuticals reported 1.5M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
Akebia Therapeutics AKBA:US $ 36.27M 3.15M
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Anika Therapeutics ANIK:US 35.34M 111K
Bristol Myers Squibb BMY:US $ 2142M 38M
Clovis Oncology CLVS:US $ 13.23M 1.27M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
Halozyme Therapeutics HALO:US $ 97.62M 49.85M
Heron Therapeutics HRTX:US $ 61.32M 4.85M
Moderna Inc MRNA:US 1.92B 21M
Ptc Therapeutics PTCT:US $ 15M 0.28M
Puma Biotechnology PBYI:US $ 6.66M 0.61M
Takeda 4502:JP Y 927511M 74344M
Teva Pharmaceutical TEVA:IT 4.05B 37M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
Vanda Pharmaceuticals VNDA:US 1.5M 206K
Veracyte VCYT:US $ 14.6M 2.23M